High Throughput Testing for Presence of Microorganisms in a Biological Sample
    21.
    发明申请
    High Throughput Testing for Presence of Microorganisms in a Biological Sample 审中-公开
    生物样品中微生物存在的高通量测试

    公开(公告)号:US20090306230A1

    公开(公告)日:2009-12-10

    申请号:US12161829

    申请日:2007-01-23

    摘要: Provided are methods and apparatus for high throughput testing of biological samples that may or may not comprise microorganisms. The methods include the use of a diagnostic multiplexing panel (DMP) specifically designed for the simultaneous identification of a plurality of potential microorganisms that may be present in the biological sample via a primer extension reaction directed a highly conserved nucleic acid sequences in the microorganisms under test. The biological sample is typically immobilised on a solid substrate at a first location before being transferred to a second location for analysis using the DMP. The methods and apparatus of the invention are particularly suited to diagnosis of the presence of infectious pathogens in the biological sample, for example for diagnosis of sexually transmitted infection.

    摘要翻译: 提供了用于生物样品的高通量测试的方法和装置,其可以包含或可以不包含微生物。 所述方法包括使用专门设计用于通过引导延伸反应同时鉴定可能存在于生物样品中的多种潜在微生物的诊断多路复用面板(DMP),所述引物延伸反应针对待测微生物中的高度保守的核酸序列 。 生物样品通常在第一位置固定在固体基质上,然后转移到第二位置以便使用DMP进行分析。 本发明的方法和装置特别适用于诊断生物样品中感染性病原体的存在,例如用于诊断性传播感染。

    Combination of a Cdk Inhibitor and Cs-682 or a Metabolite Thereof
    22.
    发明申请
    Combination of a Cdk Inhibitor and Cs-682 or a Metabolite Thereof 有权
    Cdk抑制剂和Cs-682或其代谢物的组合

    公开(公告)号:US20070270442A1

    公开(公告)日:2007-11-22

    申请号:US10581585

    申请日:2004-12-03

    摘要: A first aspect of the invention relates to a combination comprising a CDK inhibitor and 1-(2-C-cyano-2-dioxy-β-D-arabino-pentofuranosyl)-N4-palmitoyl cytosine, or a metabolite thereof. A second aspect of the invention relates to a pharmaceutical product comprising a CDK inhibitor and 1-(2-C-cyano-2-dioxy-β-D-arabino-pentofuranosyl)-N4-palmitoyl cytosine, or a metabolite thereof, as a combined preparation for simultaneous, sequential or separate use in therapy. A third aspect of the invention relates to a method of treating a proliferative disorder, said method comprising simultaneously, sequentially or separately administering a CDK inhibitor and 1-(2-C-cyano-2-dioxy-β-D-arabino-pentofuranosyl)-N4-palmitoyl cytosine, or a metabolite thereof, to a subject.

    摘要翻译: 本发明的第一方面涉及包含CDK抑制剂和1-(2-C-氰基-2-二氧基-β-D-阿拉伯 - 戊呋喃糖基)-N4-棕榈酰胞嘧啶或其代谢物的组合。 本发明的第二方面涉及包含CDK抑制剂和1-(2-C-氰基-2-二氧基-β-D-阿拉伯 - 戊呋喃糖基)-N4-棕榈酰胞嘧啶或其代谢物的药物产品,作为 用于治疗同时,连续或分开使用的联合制剂。 本发明的第三方面涉及一种治疗增殖性疾病的方法,所述方法同时依次或分别施用CDK抑制剂和1-(2-C-氰基-2-二氧基-β-D-阿拉伯 - 戊呋喃糖基) -N4-棕榈酰胞嘧啶或其代谢产物。

    Power semiconductor device
    23.
    发明申请
    Power semiconductor device 有权
    功率半导体器件

    公开(公告)号:US20060286732A1

    公开(公告)日:2006-12-21

    申请号:US11449940

    申请日:2006-06-09

    摘要: A power semiconductor device that includes a plurality of gate structure each having a gate insulation of a first thickness, and a termination region, the termination including a field insulation body surrounding the active region and having a recess that includes a bottom insulation thicker than the first thickness.

    摘要翻译: 一种功率半导体器件,其包括各自具有第一厚度的栅极绝缘体的多个栅极结构和端接区域,所述端子包括围绕所述有源区域的场绝缘体,并且具有凹部,所述凹部包括比所述第一厚度更厚的底部绝缘体 厚度。

    Markers for roscovitine
    24.
    发明申请
    Markers for roscovitine 审中-公开
    roscovitine的标记

    公开(公告)号:US20060188898A1

    公开(公告)日:2006-08-24

    申请号:US11238251

    申请日:2005-09-29

    IPC分类号: C12Q1/68 A61K31/522

    摘要: The present invention relates to pharmacodynamic markers for CDKIs including the candidate 2,6,9-tri-substituted purine known as roscovitine. The identity of these markers facilitates the convenient identification of roscovitine-like activity both in vitro and in vivo.

    摘要翻译: 本发明涉及CDKI的药效学标志物,其包括称为roscovitine的候选2,6,9-三取代嘌呤。 这些标记的身份有助于在体外和体内方便地鉴定类似罗素维生素的活性。